
Space Exploration Technologies, widely recognized as SpaceX, recently made its stock market debut on June 12th, experiencing an initial surge past $200 before stabilizing. While one might anticipate a general uplift across the space industry, this hasn't been the case for all players. Rocket Lab, another significant entity in the sector, saw its shares decline by approximately 6.6% after SpaceX's trading began.
Rocket Lab's financial overview presents a nuanced picture. The company has demonstrated impressive revenue growth and is steadily reducing its negative EBITDA. However, its operations, including the development, construction, and launch of rockets and spacecraft, continue to consume substantial capital, reflecting the inherently high costs of the space business.
Rocket Lab's existing primary launch vehicle, the Electron, is designed for smaller payloads, capable of carrying about 320 kg. This stands in contrast to SpaceX's Falcon 9, which can handle significantly larger payloads of around 22,000 kg. This difference in capacity profoundly impacts the scale and value of contracts available to launch providers. Nevertheless, this dynamic is poised for a significant shift with the impending launch of Rocket Lab's Neutron rocket, despite previous delays, which is expected by the end of the year.
If the Neutron rocket launches as planned and performs successfully, it could open up entirely new revenue streams for Rocket Lab, allowing it to more effectively compete with SpaceX, which currently dominates the market. Rocket Lab anticipates the Neutron will offer a cost-effective alternative to the Falcon 9, potentially at a notable discount.
Even after a recent market adjustment, Rocket Lab's valuation remains considerably high. With revenues nearing $680 million over the past year and a market capitalization of roughly $68 billion, its price-to-sales (P/S) ratio stands at a substantial 100. While this might seem steep, it is comparatively lower than SpaceX's P/S ratio of 130. Despite its high valuation, there is a belief that Rocket Lab possesses greater potential for growth that could justify its current market assessment compared to its larger competitor.
Investing in Rocket Lab stock involves a high degree of risk and may not be suitable for all investors. However, for those with a long-term investment horizon and a tolerance for risk, it could represent an intriguing opportunity. Despite both companies having relatively high P/S ratios, Rocket Lab is seen by some as having more room to grow into its valuation than SpaceX, suggesting a greater upside potential.